about
Comparison of family history and SNPs for predicting risk of complex diseaseCancer genetic risk assessment for individuals at risk of familial breast cancerSusceptibility pathways in Fanconi's anemia and breast cancerVariation of breast cancer risk among BRCA1/2 carriers.Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriersThe importance of BRCA1 and BRCA2 genes mutations in breast cancer developmentHereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic MedicineThe biological effects and clinical implications of BRCA mutations: where do we go from here?Finding all BRCA pathogenic mutation carriers: best practice modelsNew challenges for BRCA testing: a view from the diagnostic laboratoryOvarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionThe clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancerDNA repair targeted therapy: The past or future of cancer treatment?Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screeningThe Consequences of a BRCA Mutation in WomenOlaparib in the management of ovarian cancerInherited pancreatic cancer syndromesPersonalised cancer medicineThe genetics and neuropathology of Alzheimer's diseaseDistribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast CancerChallenging and complex decisions in the management of the BRCA mutation carrierGenetic risk prediction in complex diseaseFeasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directionsIdentification et prise en charge des femmes ayant des antécédents familiaux de cancer du sein: Guide pratique à l’intention des médecinsIdentification and management of women with a family history of breast cancer: Practical guide for cliniciansBreast cancer screening: an evidence-based updatePersonalized assessment and management of women at risk for breast cancer in North AmericaBias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation CarriersDietary Patterns, Genes, and Health: Challenges and Obstacles to be OvercomePALB2: the hub of a network of tumor suppressors involved in DNA damage responsesCancer susceptibility and reproductive trade-offs: a model of the evolution of cancer defencesPioneering geneticist Mary-Claire King receives the 2014 Lasker~Koshland Special Achievement Award in Medical ScienceRationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidenceIntegration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical LaboratoryContralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysisA frailty-model-based approach to estimating the age-dependent penetrance function of candidate genes using population-based case-control study designs: an application to data on the BRCA1 gene.
P2860
Q21144905-BBF70EEB-09BB-46E7-B3DE-3E95CCAB0021Q24203650-BA3C122C-B9CE-44A6-B333-D8D4CBD2C0B0Q24628760-96E811BF-39D9-49E5-A7A6-054B1ED71200Q24646346-7D82F5A0-7F2C-49E0-B643-02E533A54AE8Q24654487-92100DBE-7ABB-4AB6-B5CB-5645150652F5Q26738830-22CA9051-A114-4AE9-B13B-34C517CF0A5BQ26740273-BBC7B2CD-73AB-4574-BB64-27DD5798629EQ26741851-25A134E1-2E62-419C-AE31-4DD01DE77EA2Q26741854-996AFF2B-950F-4BCA-96F5-0FB45C247D8BQ26741855-4B1C685A-CF6F-4170-B651-5E653D25DA91Q26744525-FE4A6F90-55AE-47C0-8D57-7E79E255C37DQ26766285-582B9BD3-54AC-40D9-836B-61DEBE2EE228Q26768679-F544ABA1-1E8A-43A8-8933-DCD2D299F814Q26770123-5614DE9E-5F83-4F43-B9D1-D219A8F49683Q26777891-9A80F880-FB18-4B88-A07C-F114F6FEADDEQ26797166-3889CD89-2E79-4EE0-A58D-88AF12D2FA4CQ26853530-FCD006AF-3DC4-4C96-8258-D5A86EC8F61CQ26991908-0F7F632F-F00A-4DAF-B293-F57830E4B881Q26998097-6323533E-C792-4C36-A78C-CD80B5DC5E45Q27023165-3DB5A2E1-1363-49E1-B72A-B8575A9E7E6BQ27026559-EC77AEF4-E155-421E-BA03-C1202ACAA1C8Q27027720-16BF40FE-788E-44B7-A902-662EFE92DB8DQ27316521-086AF15E-EA85-4792-A8BE-078BCA2DAE71Q28071345-487D4700-4625-471D-9A78-BCBF7127ED06Q28077316-B5308451-39DC-4F75-AEDF-E42B748426D2Q28077578-4A2A5D7B-983E-4F08-88E3-3072A8E49322Q28081267-C45B736D-DB46-427D-B9E4-3451108D3F56Q28083876-2C97DC1F-716F-46C4-9FA4-0B322B8B6044Q28085448-F6C47B8B-FCC8-42BD-BDB8-A52B18C00C77Q28085623-32151C98-8678-4F8A-8A78-00C0DE8E890DQ28243398-F3BB8AFA-CCE6-46A1-91E7-0D7FB7ECAD03Q28607310-B5192D32-D0DF-47C1-80A1-9A1087C1F69BQ28654820-0BA1832F-8B14-46C2-9032-AD37E8F00365Q30250107-CFA1E9D6-99EC-407C-8C24-739CC9373361Q30275132-20525334-5F2A-457A-B610-773016B859F2Q30370475-AD57F77D-8EED-4648-B33A-9636FAAB4234Q30404123-01895BC1-0B00-4F61-BEF0-38FE2220C0C7Q30692732-CEF29209-F9FB-463C-A99C-211578387730Q31048641-CB259619-E284-4035-9B1C-B436028ACDCAQ33408340-DB76DDA6-071A-42F7-A96C-8776C0C0A112
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Meta-analysis of BRCA1 and BRCA2 penetrance
@ast
Meta-analysis of BRCA1 and BRCA2 penetrance
@en
Meta-analysis of BRCA1 and BRCA2 penetrance
@nl
type
label
Meta-analysis of BRCA1 and BRCA2 penetrance
@ast
Meta-analysis of BRCA1 and BRCA2 penetrance
@en
Meta-analysis of BRCA1 and BRCA2 penetrance
@nl
prefLabel
Meta-analysis of BRCA1 and BRCA2 penetrance
@ast
Meta-analysis of BRCA1 and BRCA2 penetrance
@en
Meta-analysis of BRCA1 and BRCA2 penetrance
@nl
P2860
P3181
P356
P1476
Meta-analysis of BRCA1 and BRCA2 penetrance
@en
P2093
Giovanni Parmigiani
Sining Chen
P2860
P304
P3181
P356
10.1200/JCO.2006.09.1066
P407
P577
2007-04-10T00:00:00Z